Atlas Trials

JHL Biotech, Inc.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch JHL Biotech, Inc.

RecordFirmDate
A Study to Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Patients (NCT03670888)JHL Biotech, Inc.2018-11-16
A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (NCT03670901)JHL Biotech, Inc.2018-11-13
A Comparative Safety and Pharmacokinetic Study of JHL1922 and Pulmozyme® in Healthy Subjects (NCT03586076)JHL Biotech, Inc.2018-01-26

Track JHL Biotech, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.